Application for quotation of securities - TLX

Sep 14, 2026 at 2:41 AM EDT · Issued by Telix Pharmaceuticals Limited via ASX

Filed with ASX · Sep 14, 2026 at 2:41 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-tlx-3

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 7Announcement SummaryEntity nameTELIX PHARMACEUTICALS LIMITEDAnnouncement TypeNew announcementDate of this announcementMonday September 14, 2026The +securities to be quoted are:Please refer...

View Attachment

6ix hasn’t read this filing yet.

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

FDA Approves Telix Brain Cancer Imaging Drug PixclaraSep 13
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment ConferenceSep 9
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA PathwaySep 2
Telix Completes Enrollment in Phase 3 BiPASS StudySep 1
Telix Appoints David Gill as ChairSep 1

Later from Telix Pharmaceuticals

Telix and ITM Join Forces to Create Radiopharma PowerhouseSep 20
Telix and ITM Join Forces to Create a Radiopharmaceutical PowerhouseSep 20
Grant of waivers of Listing Rule 7.3.4Sep 21
Appendix 3Y Change in Director Interest-D GillSep 25
Change in substantial holdingSep 25

All Telix Pharmaceuticals news releases

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals